Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.10.0.1
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - 6 months ended Jun. 30, 2018 - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Deficit [Member]
Non-Controlling Interest [Member]
Total
Balance at Dec. 31, 2017 $ 1 $ 40,895 $ 33,349,144 $ (26,082,960) $ 7,307,080
Balance, shares at Dec. 31, 2017 1,000 40,895,037        
Issuance of shares and warrants for cash $ 155 465,345 465,500
Issuance of shares and warrants for cash, shares 155,167        
Issuance of shares for cash $ 739 2,584,026 2,584,765
Issuance of shares for cash, shares 738,504        
Issuance of shares for services $ 1,489 7,596,261 7,597,750
Issuance of shares for services, shares 1,488,050        
Shares purchased, not issued as of statement date $ 190 474,810 475,000
Shares purchased, not issued as of statement date, shares 190,000        
Shares issued for purchase of patents $ 200 949,800 950,000
Shares issued for purchase of patents, shares 200,000        
Recognition of Non-Controlling Interest attributable to Spirulinex (662,721) 662,721
Capital contributed by minority joint venturers 1,390 1,390
Net loss (9,839,141) (164,470) (10,003,611)
Balance at Jun. 30, 2018 $ 1 $ 43,668 $ 44,756,665 $ (35,922,101) $ 499,641 $ 9,377,874
Balance, shares at Jun. 30, 2018 1,000 43,666,758